The Genentech Foundation is a U.S.-based, private charitable foundation whose donations are made possible by contributions from Genentech. Genentech is committed to being a strong corporate citizen, and the Genentech Foundation is one of the most important ways in which we give back to our communities.
Our Board of Directors consists of Genentech employees of diverse backgrounds who are passionate about providing resources to historically excluded and underrepresented students to help them thrive in their science and medical education.
Allen Napetian, Board Chair and Vice President, Site Services
Fritz Bittenbender, Sr. Vice President and Head of Genentech Public Affairs & Access
Fred Brown, PharmD, Principal National Account Executive
Cori Davis, PhD, Chief People Officer
Caroline DeMarco, Vice President, Customer Engagement, Northeast Region
Hongmei Huang, PhD., Vice President, Development Sciences Informatics
Colby Leno, Vice President Global Product Strategy, GI/GU/Cancer Immunotherapy Franchise
Laura Resnansky, Vice President and Global Head of Clinical Operations - Immunology, Infectious Diseases, Ophthalmology, and Neuroscience (I2ON)
Patricia (Patty) Siguenza, Vice President, BioAnalytical Sciences
Dana Spencer, Sr. Director, Therapeutic Area & Business Training
Allen is Vice President and Head of Site Services at Genentech. He is accountable for Genentech's corporate real estate portfolio, site engineering, facilities management, utilities operations, security, environmental health and safety, environmental sustainability, workplace strategies, transportation, and several key workplace services.
Allen has over twenty-eight years of site and global experience in the pharmaceutical industry across clinical and commercial Manufacturing and Quality. He is an execution-oriented and multi-cultural leader with a proven track record of partnership and collaboration in drug substance, drug product, and supply chain management operations. With a unique combination of creativity, empathy and results focus, Allen builds strong teams and unlocks high performance and engagement through his servant leadership style. He has successfully delivered on ambitious and innovative change initiatives. He is also recognized for leading organizational transformations with a genuine interest in employee development, diversity and well-being. Allen first joined Genentech in 1992 and has since worked in South San Francisco, Singapore, and Hillsboro locations.
Allen graduated from the University of California at Davis with a Bachelor of Science degree in Biology and earned an MBA from Saint Mary’s College of California. Outside of work, he can be found listening to vinyl records with his son at the local music store, spending time with his wife walking through downtown Millbrae, and riding his motorcycle through the Bay Area.
"It's a privilege to be a part of the Genentech Foundation as there is no greater honor than to be of service to our community and to foster a better future for others."
Fritz Bittenbender is Senior Vice President and Head of Genentech Public Affairs & Access.
In this capacity, he has oversight of our Access & Policy Strategy, Channel & Contract Management, Charitable Giving, Corporate Communications, and External Affairs including Government Affairs & Policy and Patient Advocacy Relations. In addition to his role on the Genentech Executive Committee, he serves as a member of Genentech’s US Leadership Team.
Prior to joining Genentech, he served as Executive Vice President at the Biotechnology Innovation Organization (BIO). There, Fritz had oversight of a fully-integrated Public Affairs department that included federal and state government relations, communications, alliance development, and membership services. Fritz and his team acted as BIO’s liaison to patient advocacy organizations, physician and payer groups, state and national business organizations, and federal, state, and local elected officials across the country.
Fritz has significant industry experience. Prior to BIO, he served as Vice President of Global Public Affairs at Cephalon and President of the CephalonCares Foundation.
Before joining Cephalon in 2005, Fritz served as President of Pennsylvania BIO, the statewide trade association for the biopharmaceutical industry. Prior to his tenure at Pennsylvania BIO, Fritz was Secretary of Administration, the chief operating officer for the Commonwealth of Pennsylvania, as well as Deputy Chief of Staff to former Pennsylvania Governor Tom Ridge.
Fritz is a graduate of the University of Pennsylvania and the Fels School of Government at the University of Pennsylvania.
Fred is a Principal National Account Executive on the National Access Decisions (NAD) Team responsible for contributing to the strategic vision and execution of business priorities across the Genentech Employer Market Segment. In this role, Fred partners across the Customer Engagement organization to cultivate relationships, build strategies and pull through collaborative efforts supporting Regional Business Coalitions, US Employer Thought Leaders and Benefit Design Consultant firms.
Fred recently joined the NAD Team from the OK/AR (A'ROK) ecosystem, where he served as a Healthcare Market Director. Here, he was able to expand Genentech's partnership with the OU Stephenson Cancer Center through an array of community outreach and engagement experiences impacting Black, Brown, and Rural patients. Before transitioning into the Ecosystem, Fred was a part of the Hematology Field Leadership Team and the Lung| GI Marketing Team where he oversaw Genentech’s LGI KOL strategy, including internal and external launch planning.
Fred joined Genentech in 2014 following his time working in Pharmacy Benefits Management as a Clinical Manager with CVS Caremark. During this time he was responsible for the building and management of clinical programming and pharmacy benefits for Large Employer Groups located in the Western United States.
He is a graduate of the Florida A&M College of Pharmacy and Pharmaceutical Sciences, where he received his Doctorate of Pharmacy degree prior to completing a PGYI Post Doctoratoral Residency program with CVS Caremark.
In addition to serving on the Genentech Foundation Board, Fred volunteers at his Church serving as the Assistant Pastor, is Vice Chair of the Power to Give Foundation and actively works as Student Mentor focused on increasing minority representation in the biotech industry. He enjoys golfing, grilling and most importantly spending time with his wife Bethany (GNE Harmony, iTX HD) and their daughter, Ayden, and son, Frederick “Solomon.”
Cori Davis became Genentech's Chief People and Culture Officer in April 2022. In this role, she leads the strategy to foster an inclusive and inspiring environment where the company’s 13,500 employees can grow, thrive, and unlock their full potential to contribute to patients and society.
Since joining Genentech in 2009, Cori has provided organization development and human resources business partnering support to the Corporate Groups; U.S. Commercial, Medical Affairs, and Government Affairs, and Global Product Development.
In addition to leading the People and Culture community, Cori is a member of the Genentech Executive Committee and the Roche Global Pharma People & Culture Enabling Team. She is also the Executive Sponsor of the Genentech Diversity Equity and Inclusion Board, and serves on the Executive Committee of the Bay Area Council, a group of business leaders working to ensure the Bay Area is a globally competitive place to work and live.
An innovative leader with more than 25 years of human resources experience, Cori brings enterprise thinking, empathy, results orientation and a common sense approach to problem solving.
Cori has a Ph.D. in Organizational Psychology from Michigan State University.
A strong believer in giving back to her community, Cori volunteers with BuildOn, and enjoys spending time with her family exploring new places and training their chihuahua puppy.
As a member of the Customer Engagement Leadership Team on the Customer, Marketing and Government (CMG) Team at Genentech, Caroline partners with the National Accounts, Medical Affairs and Therapeutic Area Squad Teams to ensure that their innovation reaches the patients they serve and they are responsible for developing the skills & capabilities of the Northeast regional team.
Caroline has over three decades of pharmaceutical experience. With a finance background, her experience spans sales, contracting, finance, marketing, human resources, payer, strategic planning, commercial operations, capability building and talent management including global responsibilities. Before joining Genentech in 2020, Caroline was at GlaxoSmithKline (GSK) as VP, Global & Implementation Lead where she was responsible for driving the strategic change & implementation plan for the transformation and subsequent launch a new Biopharma company and the separation and launch of a new global Consumer Healthcare Company for GSK.
Outside of work, Caroline sits on the Board of the Trustees for The Haverford School (Haverford.org) in Haverford, PA--a private all boys school that has been educating boys to be men of character since 1884. Caroline is based in Philadelphia, PA and is a leader serving her community in several capacities. She is a member of the Executive Forum of Women (foew.com), the Immediate President of The Penn Towne Chapter of The Links, Inc. 2015-2019 (penntownelinks.org), a Charter member the Omega Mu Omega Chapter of Alpha Kappa Alpha Sorority, Inc. (AKA1908.org) and a member of Jack & Jill of America, The Philadelphia Chapter (jackandjillinc.org).
By connecting science and technology, Hongmei Huang leads organizational drives to transform the data and digital landscape for the advancement of medicines and healthcare. She is an accomplished scientific and informatics leader with over 25 years of experience in the Pharmaceutical Biotech Industry, after receiving her Ph.D. in BioOrganic Chemistry.
Hongmei is currently the Vice President of Development Sciences Informatics at Genentech, providing strategic leadership for the data ecosystem for translational sciences, and is among the key leaders for the pan Roche R&D data initiative. She is also leading the Pharma Technology Development data strategy and digital transformation ad interim as part of the corporate talent flow. Hongmei is passionate about serving the broader community and developing people, volunteering her time mentoring professionals and students.
"I am honored to serve alongside my fellow board members and work toward “a world where health and prosperity are accessible to all”. A passion of mine is fostering a diverse talent pipeline by bridging the opportunity gaps among young people from different backgrounds."
Colby Leno is the Vice President of the GI/GU/Cancer Immunotherapy Franchise in Global Product Strategy, Oncology. In this role, he leads a team of Lifecycle Leaders and Disease Area Directors accountable for disease area strategies and developing and commercializing our portfolio of oncology assets.
Since joining Genentech in 2004, Colby has held a variety of leadership roles across the Oncology and Immunology Therapeutic Areas. He is an accomplished executive with over 20 years of experience throughout every stage of the product lifecycle and value chain. Colby is a highly regarded people leader with a record of inspiring & influencing to enable results across large, complex, and matrixed global organizations. As a passionate champion for corporate Diversity and Inclusion, he is active in several cross-organizational initiatives such as Roche D&I Core Team, Ambassador for Roche Women Professionals Group (WPG), and Genentech Women Professionals (GWP).
Colby completed his undergraduate studies in Biology, and graduate studies in Healthcare Management and Administration at Springfield College, Springfield, MA. He lives in San Francisco, CA with his wife and highly feisty 8-year-old daughter.
Laura joined Genentech in 1999 working in clinical operations on Pulmozyme and supporting the thromoblytics franchise. Her background is in Nursing and she began her career in drug development as a Study Coordinator for NIH sponsored studies. Following this she worked at a CRO as a Monitor and then moved on to a role in Drug Safety at Boehringer Ingelheim. Throughout her 25 years in the industry her work experience has spanned multiple roles and across various therapeutic areas including respiratory, cardiovascular diseases, immunologic disorders, rheumatology, ophthalmology, and neurological diseases.
Patty leads a top-notch department dedicated to enabling drug development by creating bioanalytical strategies, methods, and providing foundational data for non-clinical and clinical studies to advance Genentech molecules through all stages of drug development and post marketing.
Patty joined Genentech in the late 1980’s, after receiving her B.S. in Clinical Sciences, San Francisco State University, having attended College of San Mateo prior to SFSU. Throughout her career, she has made significant contributions to Genentech’s US and ex-US product development and approvals in the areas of oncology, autoimmunity, and asthma drugs. Patty strongly believes in Genentech’s commitment to patients, and the endless possibilities to advance science.
In 2020, The San Francisco Business Times recognized Patty as one of the “Most Influential Women in the Bay Area”. Patty is very passionate about education and people development, volunteering her time mentoring professionals and college students, as well as recent graduates. She chairs the San Mateo County Community Colleges Foundation Board, is a member of the SFSU Foundation Board, and serves the Cañada College President’s Advisory Group.
Dana Spencer is the Sr Director of Therapeutic Area and Business Training for CMG Training and Development. In this role, Dana oversees and leads the development and implementation of training programs and initiatives across all therapeutic and business areas. Her responsibilities also include furthering the vision, strategy and operations of T&D.
A healthcare veteran with 20+ years in the pharmaceutical and biotechnology industry, Dana is known for her passion for patients, drive for results and ability to lead change. Prior to joining Genentech in 2016 as the Hematology Training Manager, Dana held sales, sales leadership, training and operations positions for both start up and big pharmaceutical companies.
Dana is a native of Chicago, Illinois and a graduate of Northern Illinois University, majoring in Cardiac Rehabilitation. She received a Master of Divinity from the Samuel Dewitt Proctor School of Theology at Virginia Union University. Dana serves as an Itinerant Elder on the ministerial staff at First A.M.E. Oakland. In her ministerial role, she is responsible for Christian Education activities and leads the women’s group, Sister 2 Sister. Dana is a member of Women of Color in Pharma (WOCIP), Healthcare Businesswomen’s Association (HBA) and a Diamond Life member of Delta Sigma Theta Sorority, Inc.
Dana lives in the Bay Area with her husband and they enjoy traveling and learning about other cultures.
"My passion for making meaningful change is based on my belief that every person should be afforded equal opportunities for success. It is an honor to serve on the Genentech Foundation Board focusing on solutions that will positively impact lives."